Structure-function analysis of the anti-proliferative effect of the human guanylate binding protein-1 (GBP-1) in endothelial cells

被引:0
|
作者
Töpolt, K [1 ]
Guenzi, E [1 ]
Lubeseder-Martellato, C [1 ]
Jörg, A [1 ]
Naschberger, E [1 ]
Stürzl, M [1 ]
机构
[1] GSF, Natl Res Ctr Environm & Hlth, Inst Mol Virol, Dept Virus Induced Vasculopathy, Neuherberg, Germany
来源
22ND MEETING OF THE EUROPEAN SOCIETY FOR MICROCIRCULATION: MICROCIRCULATION AND VASCULAR BIOLOGY | 2002年
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammatory cytokines (IC) are potent inhibitors of endothelial cell proliferation. As a specific mediator of the anti-proliferative effect of IC on endothelial cells (EC) we identified the large GTPase human guanylate binding protein-1 (GBP-1). Ectopic expression of GBP-1 in EC inhibited angiogenic growth factor (AGF)-induced proliferation, whereas inhibition of IC-induced GBP-1 expression by GBP-1 antisense RNA abrogated the anti-proliferative effect of IC. GBP-1 selectively inhibited the proliferation of endothelial cells in the absence of apoptosis and without affecting adhesiveness for monocytes, morphogenesis or ERK 1/2 activation. Structure-function-analysis conveyed that the anti-proliferative effect is mediated specifically by the helical domain of GBP-1 and independent of isoprenylation or GTP-hydrolysis.
引用
收藏
页码:215 / 219
页数:5
相关论文
共 50 条
  • [1] Human guanylate-binding protein-1 (GBP-1) in colorectal carcinoma
    Britzen-Laurent, Nathalie
    Lipnik, Karoline
    Naschberger, Elisabeth
    Kuhn, Elisabeth
    Hohenadl, Christine
    Sturzl, Michael
    CANCER RESEARCH, 2010, 70
  • [2] THE ANTI-ANGIOGENIC FACTOR GUANYLATE BINDING PROTEIN-1 (GBP-1) IN SYSTEMIC SCLEROSIS PATIENTS
    Scarsi, M.
    Andreoli, L.
    Airo, P.
    Herrmann, M.
    Sturzl, M.
    Naschberger, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S169 - S169
  • [3] Guanylate binding protein-1 (GBP-1) regulates intestinal epithelial barrier function through effects on apoptosis
    Schnoor, M.
    Betanzos, A.
    Weber, D. A.
    Parkos, C. A.
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2009, 88 : 66 - 66
  • [4] The Large GTPase Guanylate-Binding Protein-1 (GBP-1) Promotes Mitochondrial Fission in Glioblastoma
    Kalb, Ryan C.
    Nyabuto, Geoffrey O.
    Morran, Michael P.
    Maity, Swagata
    Justinger, Jacob S.
    Nestor-Kalinoski, Andrea L.
    Vestal, Deborah J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [5] Guanylate binding protein 1 (GBP-1) is a biomarker for lung adenocarcinoma invasion
    Mimae, Takahiro
    Hamai, Yoichi
    Kimura, Yuri
    Okada, Morihito
    CANCER SCIENCE, 2021, 112 : 500 - 500
  • [6] Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus
    Anderson, SL
    Carton, JM
    Lou, J
    Xing, L
    Rubin, BY
    VIROLOGY, 1999, 256 (01) : 8 - 14
  • [7] Cell motility and invasiveness are promoted by guanylate binding protein 1, GBP-1 in lung adenocarcinoma
    Mimae, Takahiro
    Yamakita, Ichiko
    Tsutani, Yasuhiro
    Miyata, Yoshihiro
    Ito, Akihiko
    Okada, Morihito
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Guanylate binding protein 1 (GBP-1) promotes cell motility and invasiveness of lung adenocarcinoma
    Yamakita, Ichiko
    Mimae, Takahiro
    Tsutani, Yasuhiro
    Miyata, Yoshihiro
    Ito, Akihiko
    Okada, Morihito
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 518 (02) : 266 - 272
  • [9] Guanylate binding protein-1 (GBP-1) is upregulated in intestinal epithelia under inflammatory conditions, localizes to tight junctions and regulates epithelial barrier function
    Schnoor, Michael
    Betanzos, Abigail
    Parkos, Charles
    FASEB JOURNAL, 2008, 22
  • [10] Cytokine-Induced Guanylate Binding Protein 1 (GBP1) Release from Human Ovarian Cancer Cells
    Carbotti, Grazia
    Petretto, Andrea
    Naschberger, Elisabeth
    Stuerzl, Michael
    Martini, Stefania
    Mingari, Maria Cristina
    Filaci, Gilberto
    Ferrini, Silvano
    Fabbi, Marina
    CANCERS, 2020, 12 (02)